36
Participants
Start Date
February 28, 2011
Primary Completion Date
May 31, 2011
Dabigatran etexilate plus dronedarone
dabigatran etexilate 150 mg plus dronedarone 400 mg as single dose
Dabigatran etexilate
150 mg as single dose
Dabigatran etexilate plus dronedarone
dabigatran etexilate 150 mg plus dronedarone 400 mg as single dose (staggered administration)
Dabigatran etexilate plus dronedarone
dabigatran etexilate 150 mg single dose plus dronedarone 400 mg bid
Dabigatran etexilate plus dronedarone
dabigatran etexilate 150 mg single dose plus dronedarone 400 mg bid (staggered administration)
1160.112.1 Boehringer Ingelheim Investigational Site, Ulm
Lead Sponsor
Boehringer Ingelheim
INDUSTRY